Table 1 Demographic and clinical data
From: Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients
Patient | Gender | Age (years) | Weight (kg) | MV | Cr Cl (mL/min) | Infection focus | Vasop | Surgery | Charlson | SAPS II | SOFA |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 73 | 77 | No | 76.7 | Lung | Yes | No | 4 | 26 | 4 |
2 | F | 58 | 55 | Yes | 25.0 | Lung | No | No | 3 | 44 | 5 |
3 | F | 77 | 65 | No | 66.7 | Intra-abdominal | No | Yes | 9 | 48 | 4 |
4 | M | 79 | 78 | No | 23.3 | Intra-abdominal | No | Yes | 6 | 38 | 2 |
5 | F | 78 | 85 | Yes | 81.7 | Bacteremia | No | No | 9 | 47 | 4 |
6 | M | 73 | 78 | Yes | 65.0 | Unknown | Yes | Yes | 5 | 43 | 8 |
7 | F | 76 | 80 | Yes | 43.3 | Intra-abdominal | Yes | Yes | 3 | 72 | 8 |
8 | M | 53 | 60 | No | 15.0 | Skin/Soft tissue | Yes | No | 6 | 34 | 6 |
9 | F | 71 | 90 | Yes | NA | Intra-abdominal | No | Yes | 6 | 37 | 3 |
10 | M | 41 | 80 | Yes | 116.7 | Intra-abdominal | No | No | 1 | 35 | 5 |
11 | M | 51 | 70 | Yes | 41.7 | Lung | Yes | No | 4 | 50 | 9 |
12 | F | 90 | 75 | Yes | NA | Central nervous system | No | Yes | 6 | 58 | 6 |
13 | M | 34 | 63 | Yes | 95.0 | Lung | No | No | 0 | 32 | 2 |
14 | M | 67 | 80 | Yes | 226.7 | Lung | No | No | 3 | 47 | 4 |
15 | F | 76 | 100 | No | 51.7 | Intra-abdominal | No | Yes | 3 | 47 | 2 |
Median [IQR] | 73 [21] | 78 [12.5] | 65.0 (40) | 4 [3] | 44 [11.5] | 4 [2.5] |